$1.64
-0.15-8.15%
Last update: Nov 10, 2:45 PM
Tenax Therapeutics Inc
TENXNASDAQ
The average analyst price target for Tenax Therapeutics is $22.50, 1276.1% above the current price. Of 9 analysts, 5 rate it Buy and 4 Hold. Targets range from $4 to $50. The latest change came on Aug 31, 2026, when Guggenheim downgraded Tenax Therapeutics from Buy to Neutral.
Price Target Range — 8 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months
